You are here

  • Home
  • Archive
  • Volume 60, Issue 8
  • Specific glycosylation of α1-acid glycoprotein characterises patients with familial Mediterranean fever and obligatory carriers of MEFV

Article info

Article menu
Download PDFPDF
Extended report
Specific glycosylation of α1-acid glycoprotein characterises patients with familial Mediterranean fever and obligatory carriers of MEFV

Authors

  • D C W Poland aDepartment of Medical Chemistry, Institute for Inflammation and Inflammatory Diseases, Faculty of Medicine, Vrije Universiteit, Amsterdam, The Netherlands, bDepartment of Medicine, Division of Gastroenterology, University Medical Centre St Radboud, Nijmegen, The Netherlands, cHeller Institute of Medical Research, Sheba Medical Centre, Tel Hashomer and Sackler School of Medicine, Tel Aviv, Israel, dDivision of Rheumatology, Department of Medicine, University Hospital, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • J P H Drenth aDepartment of Medical Chemistry, Institute for Inflammation and Inflammatory Diseases, Faculty of Medicine, Vrije Universiteit, Amsterdam, The Netherlands, bDepartment of Medicine, Division of Gastroenterology, University Medical Centre St Radboud, Nijmegen, The Netherlands, cHeller Institute of Medical Research, Sheba Medical Centre, Tel Hashomer and Sackler School of Medicine, Tel Aviv, Israel, dDivision of Rheumatology, Department of Medicine, University Hospital, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • E Rabinovitz aDepartment of Medical Chemistry, Institute for Inflammation and Inflammatory Diseases, Faculty of Medicine, Vrije Universiteit, Amsterdam, The Netherlands, bDepartment of Medicine, Division of Gastroenterology, University Medical Centre St Radboud, Nijmegen, The Netherlands, cHeller Institute of Medical Research, Sheba Medical Centre, Tel Hashomer and Sackler School of Medicine, Tel Aviv, Israel, dDivision of Rheumatology, Department of Medicine, University Hospital, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • A Livneh aDepartment of Medical Chemistry, Institute for Inflammation and Inflammatory Diseases, Faculty of Medicine, Vrije Universiteit, Amsterdam, The Netherlands, bDepartment of Medicine, Division of Gastroenterology, University Medical Centre St Radboud, Nijmegen, The Netherlands, cHeller Institute of Medical Research, Sheba Medical Centre, Tel Hashomer and Sackler School of Medicine, Tel Aviv, Israel, dDivision of Rheumatology, Department of Medicine, University Hospital, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • J Bijzet aDepartment of Medical Chemistry, Institute for Inflammation and Inflammatory Diseases, Faculty of Medicine, Vrije Universiteit, Amsterdam, The Netherlands, bDepartment of Medicine, Division of Gastroenterology, University Medical Centre St Radboud, Nijmegen, The Netherlands, cHeller Institute of Medical Research, Sheba Medical Centre, Tel Hashomer and Sackler School of Medicine, Tel Aviv, Israel, dDivision of Rheumatology, Department of Medicine, University Hospital, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • B van het Hof aDepartment of Medical Chemistry, Institute for Inflammation and Inflammatory Diseases, Faculty of Medicine, Vrije Universiteit, Amsterdam, The Netherlands, bDepartment of Medicine, Division of Gastroenterology, University Medical Centre St Radboud, Nijmegen, The Netherlands, cHeller Institute of Medical Research, Sheba Medical Centre, Tel Hashomer and Sackler School of Medicine, Tel Aviv, Israel, dDivision of Rheumatology, Department of Medicine, University Hospital, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • W van Dijk aDepartment of Medical Chemistry, Institute for Inflammation and Inflammatory Diseases, Faculty of Medicine, Vrije Universiteit, Amsterdam, The Netherlands, bDepartment of Medicine, Division of Gastroenterology, University Medical Centre St Radboud, Nijmegen, The Netherlands, cHeller Institute of Medical Research, Sheba Medical Centre, Tel Hashomer and Sackler School of Medicine, Tel Aviv, Israel, dDivision of Rheumatology, Department of Medicine, University Hospital, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  1. Dr W Van Dijk, Department of Medical Chemistry, Institute for Immunology and Inflammatory Diseases, Faculty of Medicine, Vrije Universiteit, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlandsw.van_dijk.medchem{at}med.vu.nl
View Full Text

Citation

Poland DCW, Drenth JPH, Rabinovitz E, et al
Specific glycosylation of α1-acid glycoprotein characterises patients with familial Mediterranean fever and obligatory carriers of MEFV
Annals of the Rheumatic Diseases 2001;60:777-780.

Publication history

  • Accepted January 23, 2001
  • First published August 1, 2001.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Annals of the Rheumatic Diseases